rs777668842
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001134831.2(AHI1):c.1267C>T(p.Gln423Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,600,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001134831.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AHI1 | NM_001134831.2 | c.1267C>T | p.Gln423Ter | stop_gained | 10/29 | ENST00000265602.11 | NP_001128303.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AHI1 | ENST00000265602.11 | c.1267C>T | p.Gln423Ter | stop_gained | 10/29 | 1 | NM_001134831.2 | ENSP00000265602 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152112Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000652 AC: 15AN: 229968Hom.: 0 AF XY: 0.0000806 AC XY: 10AN XY: 124104
GnomAD4 exome AF: 0.000117 AC: 170AN: 1448882Hom.: 0 Cov.: 30 AF XY: 0.000120 AC XY: 86AN XY: 719452
GnomAD4 genome AF: 0.000118 AC: 18AN: 152112Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74322
ClinVar
Submissions by phenotype
Joubert syndrome 3 Pathogenic:2
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 07, 2022 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 03, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21866095, 26092869, 28492532, 25525159, 16453322, 16155189, 31963381, 31589614) - |
Nephronophthisis Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Sydney Genome Diagnostics, Children's Hospital Westmead | May 03, 2018 | This individual is heterozygous for the c.1267C>T and c.2246C>G variants in the AHI1 gene. Both variants create premature stop codons, p.Gln423*and p.Ser749* respectively, and may result in null alleles due to nonsense-mediated mRNA decay. To our knowledge, these variants have not been reported in population databases (dbSNP, ESP, ExAC) and have not been previously associated with disease. However, other truncating mutations downstream of these amino acids have been described in the literature (Parisi et al, J Med Genet. 2006; 43(4):334-339). Both the c.1267C>T and c.2246C>G variants are considered to be pathogenic according to ACMG guidelines. - |
Joubert syndrome and related disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 22, 2023 | Variant summary: AHI1 c.1267C>T (p.Gln423X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanisms for disease. The variant allele was found at a frequency of 6.5e-05 in 229968 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in AHI1 causing Joubert Syndrome And Related Disorders (6.5e-05 vs 0.0013), allowing no conclusion about variant significance. c.1267C>T has been reported in the literature in individuals affected with Joubert Syndrome And Related Disorders (e.g. Bachmann-Gagescu_2015), including at least one compound heterozygous patient with another pathogenic variant. These data indicate that the variant is very likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 26092869). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, and classified it as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Rod-cone dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Ocular Genomics Institute, Massachusetts Eye and Ear | Apr 08, 2021 | The AHI1 c.1267C>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PVS1, PP1, PM3. Based on this evidence we have classified this variant as Pathogenic. - |
Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change creates a premature translational stop signal (p.Gln423*) in the AHI1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AHI1 are known to be pathogenic (PMID: 15322546, 16453322, 28442542, 29186038). This variant is present in population databases (rs777668842, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with Joubert syndrome or Joubert syndrome-related disorders (PMID: 16155189, 16453322, 26092869). ClinVar contains an entry for this variant (Variation ID: 217523). For these reasons, this variant has been classified as Pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Mar 13, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at